SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy(vol 210, 115454,2023)

被引：0
|
作者：
Sun, Zhenzhu [1 ,2 ]
Fang, Chongfeng [1 ,2 ]
Xu, Shasha [1 ,2 ]
Wang, Bin [1 ,2 ]
Li, Danlei [1 ,2 ]
Liu, Xiaoman [1 ,2 ]
Mi, Yafei [1 ,2 ]
Guo, Hangyuan [3 ]
Jiang, Jianjun [1 ,2 ]
机构：
[1] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Cardiol, Linhai 317000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Lab Cardiovasc Dis, Linhai 317000, Zhejiang, Peoples R China
[3] Shaoxing Univ, Coll Med, 508 Huancheng W Rd, Shaoxing 312000, Zhejiang, Peoples R China
来源：
BIOCHEMICAL PHARMACOLOGY | 2023年 / 210卷
关键词：
D O I：
10.1016/j.bcp.2023.115454
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy
    Sun, Zhengzhu
    Fang, Chongfeng
    Xu, Shasha
    Wang, Bin
    Li, Danlei
    Liu, Xiaoman
    Mi, Yafei
    Guo, Hangyuan
    Jiang, Jianjun
    BIOCHEMICAL PHARMACOLOGY, 2023, 207
  • [2] Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1
    Sun, Zhenzhu
    Lu, Wenqiang
    Lin, Na
    Lin, Hui
    Zhang, Jie
    Ni, Tingjuan
    Meng, Liping
    Zhang, Chuanjing
    Guo, Hangyuan
    BIOCHEMICAL PHARMACOLOGY, 2020, 175
  • [3] Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation
    Zhang, Lei
    Fan, Cundong
    Jiao, Hua-Chen
    Zhang, Qian
    Jiang, Yue-Hua
    Cui, Jie
    Liu, Yang
    Jiang, Yong-Hao
    Zhang, Juan
    Yang, Meng-Qi
    Li, Yan
    Xue, Yi-Tao
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [4] Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity
    Kabel, Ahmed M.
    Salama, Samir A.
    Adwas, Almokhtar A.
    Estfanous, Remon S.
    PHARMACEUTICALS, 2021, 14 (11)
  • [5] Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro
    Wei, Shanshan
    Ma, Wanjun
    Yang, Yuanying
    Sun, Taoli
    Jiang, Chuanhao
    Liu, Jian
    Zhang, Bikui
    Li, Wenqun
    BIOCHEMICAL PHARMACOLOGY, 2023, 214
  • [6] Hyperoside prevents doxorubicin-induced cardiotoxicity by inhibiting NOXs/ROS/NLRP3 inflammasome signaling pathway
    Wei, Shanshan
    Ma, Wanjun
    Jiang, Chuanhao
    Liu, Jiaqin
    Liu, Jian
    Zhang, Bikui
    Li, Wenqun
    PHYTOTHERAPY RESEARCH, 2023, 37 (09) : 4196 - 4209
  • [7] Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity
    Wei, Shanshan
    Ma, Wanjun
    Li, Xiaohui
    Jiang, Chuanhao
    Sun, Taoli
    Li, Yuanjian
    Zhang, Bikui
    Li, Wenqun
    CARDIOVASCULAR TOXICOLOGY, 2020, 20 (05) : 507 - 519
  • [8] Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity
    Shanshan Wei
    Wanjun Ma
    Xiaohui Li
    Chuanhao Jiang
    Taoli Sun
    Yuanjian Li
    Bikui Zhang
    Wenqun Li
    Cardiovascular Toxicology, 2020, 20 : 507 - 519
  • [9] CTRP5 Attenuates Doxorubicin-Induced Cardiotoxicity Via Inhibiting TLR4/NLRP3 Signaling
    Zhang, Zhaoxia
    Peng, Jianye
    Hu, Yewen
    Zeng, Gaofeng
    Du, Weiping
    Shen, Caijie
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 38 (6) : 1235 - 1244
  • [10] Knockdown of NR4A1 alleviates doxorubicin-induced cardiotoxicity through inhibiting the activation of the NLRP3 inflammasome
    Hu, Huanhuan
    Zhong, Zuoquan
    Meng, Liping
    Chen, Jiming
    Yu, Ziheng
    Lu, Kongjie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 700
12345